Health and Healthcare

Health and Healthcare Articles

All Health and Healthcare Articles

5865 Articles

Chris Lange | Mar 28, 2019 at 11:10 AM EDT

Can Proteon Therapeutics Come Back From This Chronic Kidney Disease Study?

Proteon Therapeutics shares were absolutely crushed on Thursday after the firm announced results from its late-stage trial in patients with…

Jon C. Ogg | Mar 27, 2019 at 3:55 PM EDT

Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck

According to Credit Suisse, Pfizer investors might be getting to make up some of that relative underperformance of late.

Jon C. Ogg | Mar 27, 2019 at 12:55 PM EDT

Why the Market Is Punishing Centene Over Its Planned WellCare Health Plans Acquisition

This is one of those mergers that is not getting the warm fuzzy feeling that management teams love to see.

Chris Lange | Mar 27, 2019 at 10:45 AM EDT

What’s Next for Axsome Therapeutics After This FDA Approval

Axsome shares jumped on Wednesday after the firm gave an update from the FDA regarding its AXS-05 for the treatment…

Chris Lange | Mar 27, 2019 at 8:50 AM EDT

Major Pharma Sees a Few Wild Swings in Short Interest

The March 15 short interest data have been compared with the previous figures, and short interest in most of these…

Chris Lange | Mar 27, 2019 at 8:30 AM EDT

Big Biotechs Scare Off Short Sellers

The March 15 short interest data have been compared with the previous report, and short interest in most of the…

Paul Ausick | Mar 26, 2019 at 1:25 PM EDT

Why Is Purdue Settling Oklahoma Opioid Lawsuit for $275 Million?

Tuesday afternoon, the attorney general of Oklahoma is expected to announce that the state has reached a settlement with Purdue…

Paul Ausick | Mar 25, 2019 at 1:45 PM EDT

Will Pacemakers and Other Medical Implants Be Hacked?

The U.S. FDA has proposed new guidelines to address cybersecurity threats to implanted medical devices. Comments on the guidelines are…

Chris Lange | Mar 25, 2019 at 11:15 AM EDT

Why Curis Shares Are Booming

Curis shares jumped when the firm announced that it entered into an agreement to sell rights to a portion of…

Chris Lange | Mar 25, 2019 at 9:05 AM EDT

Picking Up the Pieces: How Biogen Is Dealing With Discontinued Alzheimer’s Trial

Biogen shares made a slight gain early on Monday after the firm made an SEC filing indicating that it will…

Jon C. Ogg | Mar 21, 2019 at 4:24 PM EDT

Is Neurotrope the Default Alzheimer’s Winner After Biogen’s Implosion?

Neurotrope Inc. (NASDAQ: NTRP) may be a winner by default in the battle against Alzheimer’s disease after shares of Biogen…

Chris Lange | Mar 21, 2019 at 9:55 AM EDT

Why This Alzheimer’s Study Is Crushing Biogen Shares

Biogen shares were crushed in Thursday’s session after the firm announced that it would be discontinuing its late-stage trial for…

Jon C. Ogg | Mar 20, 2019 at 4:25 PM EDT

Why Pfizer Is Getting Deeper Into Gene Therapy

Gene therapy may become the next frontier for drug companies seeking to make billions of dollars improving or even curing…

Chris Lange | Mar 20, 2019 at 11:29 AM EDT

Pfizer Moves Over Half a Billion for Wilson Disease Treatment

Pfizer is looking to collaborate with Vivet on the development of its proprietary treatment for Wilson disease.

Jon C. Ogg | Mar 19, 2019 at 10:25 AM EDT

Bad News for AbbVie and Multiple Myeloma Patients

AbbVie and patients suffering from multiple myeloma have seen some additional bad news from the FDA.

1 … 102 103 104 105 106 … 392

Health and Healthcare Articles

All Health and Healthcare Articles

Can Proteon Therapeutics Come Back From This Chronic Kidney Disease Study?

Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck

Why the Market Is Punishing Centene Over Its Planned WellCare Health Plans Acquisition

What’s Next for Axsome Therapeutics After This FDA Approval

Major Pharma Sees a Few Wild Swings in Short Interest

Big Biotechs Scare Off Short Sellers

Why Is Purdue Settling Oklahoma Opioid Lawsuit for $275 Million?

Will Pacemakers and Other Medical Implants Be Hacked?

Why Curis Shares Are Booming

Picking Up the Pieces: How Biogen Is Dealing With Discontinued Alzheimer’s Trial

Is Neurotrope the Default Alzheimer’s Winner After Biogen’s Implosion?

Why This Alzheimer’s Study Is Crushing Biogen Shares

Why Pfizer Is Getting Deeper Into Gene Therapy

Pfizer Moves Over Half a Billion for Wilson Disease Treatment

Bad News for AbbVie and Multiple Myeloma Patients

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

Health and Healthcare Articles

All Health and Healthcare Articles

Can Proteon Therapeutics Come Back From This Chronic Kidney Disease Study?

Why Pfizer May Soon Make Up Lost Ground in Underperforming Against Merck

Why the Market Is Punishing Centene Over Its Planned WellCare Health Plans Acquisition

What’s Next for Axsome Therapeutics After This FDA Approval

Major Pharma Sees a Few Wild Swings in Short Interest

Big Biotechs Scare Off Short Sellers

Why Is Purdue Settling Oklahoma Opioid Lawsuit for $275 Million?

Will Pacemakers and Other Medical Implants Be Hacked?

Why Curis Shares Are Booming

Picking Up the Pieces: How Biogen Is Dealing With Discontinued Alzheimer’s Trial

Is Neurotrope the Default Alzheimer’s Winner After Biogen’s Implosion?

Why This Alzheimer’s Study Is Crushing Biogen Shares

Why Pfizer Is Getting Deeper Into Gene Therapy

Pfizer Moves Over Half a Billion for Wilson Disease Treatment

Bad News for AbbVie and Multiple Myeloma Patients

Is Jeff Bezos’ New Startup An Even Bigger Idea than Amazon? He Tells CNBC it Will Drive ‘Civilizational Wealth.’

Cramer Calls Intel the “Number One Name” and “More Important Than NVIDIA.” The Stock Soars Today After a Massive Double Upgrade.

‘I Feel Like It’s 1999 Again.’ CNBC Analyst Issues Dire Warning on Oracle Stock

Featured Reads

Why Delaying Social Security While Emptying Your 401(k) Can Slash Your Lifetime Taxes

Retiring With $1.8M in New Jersey Means an $11,400 Annual Tax Bill the Calculators Skip